Treatment of Adult ALL According to Protocols of the German Multicenter Study Group for Adult ALL (GMALL)

Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

1988 • 602 citations

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

2002 • 566 citations

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

2005 • 530 citations

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

2006 • 333 citations

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis

2002 • 332 citations

Improved outcome in adult B-cell acute lymphoblastic leukemia

1996 • 317 citations

Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults

1984 • 303 citations

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

2007 • 249 citations

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials

2006 • 244 citations

Imatinib compared with chemotherapy as front‐line treatment of elderly patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ALL)

2007 • 237 citations

Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission

2004 • 210 citations

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

2005 • 202 citations

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

2002 • 196 citations

Treatment of Adult Acute Lymphoblastic Leukemia

2006 • 158 citations

Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia [see comments]

1989 • 126 citations

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas

2002 • 116 citations

High Expression of the ETS Transcription Factor ERG Predicts Adverse Outcome in Acute T-Lymphoblastic Leukemia in Adults

2006 • 110 citations

Low ERG and BAALC Expression Identifies a New Subgroup of Adult Acute T-Lymphoblastic Leukemia With a Highly Favorable Outcome

2007 • 102 citations

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

2002 • 80 citations

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl–positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571)

2002 • 79 citations

Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations

2006 • 67 citations

2 Immunophenotypic classification of acute lymphoblastic leukaemia

1994 • 65 citations

CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL)

2005 • 61 citations

NUP214-ABL1 in adult T-ALL: the GMALL study group experience

2006 • 59 citations

Immunophenotypic Features of Childhood and Adult Acute Lymphoblastic Leukemia (ALL): Experience of the German Multicentre Trials ALL-BFM and GMALL

1994 • 43 citations

AIDS-associated Burkitt or Burkitt-like lymphoma: Short intensive polychemotherapy is feasible and effective

2006 • 26 citations

Clinical Relevance of Blast Cell Phenotype as Determined with Monoclonal Antibodies in Acute Lymphoblastic Leukemia of Adults

1987 • 14 citations

Dexamethasone Dose and Schedule Significantly Influences Remission Rate and Toxicity of Induction Therapy in Adult Acute Lymphoblastic Leukemia (ALL): Results of the GMALL Pilot Trial 06/99.

2005 • 11 citations

Prognostic Impact of the Expression of the TLX1 (HOX11) and TLX3 (HOX11L2) Oncogenes in Adult ALL: Experience of the German Multicenter Acute Lymphoblastic Leukemia (GMALL) Therapy Study Group.

2004 • 2 citations